Parametric Portfolio Associates’s Calithera Biosciences, Inc CALA Stock Holding History

Parametric Portfolio Associates’s Portfolio CALA Stock Details CALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-708	Closed	-$70K	–	4102
2020 Q4	$70K	Buy	708 +200	+39%	+$17.5K	﹤0.01%	3918
2020 Q3	$35K	Sell	508 -13,672	-96%	-$1.19M	﹤0.01%	3896
2020 Q2	$1.5M	Buy	14,180 +13,467	+1,889%	+$1.6M	﹤0.01%	2687
2020 Q1	$63K	Buy	713 +47	+7%	+$5.6K	﹤0.01%	3805
2019 Q4	$76K	Buy	666 +137	+26%	+$10.3K	﹤0.01%	3893
2019 Q3	$33K	Buy	+529	New	+$42.3K	﹤0.01%	3917
2019 Q2	–	Sell	-649	Closed	-$87K	–	4017
2019 Q1	$87K	Sell	649 -79	-11%	-$8.3K	﹤0.01%	3835
2018 Q4	$58K	Sell	728 -388	-35%	-$38.3K	﹤0.01%	3840
2018 Q3	$117K	Buy	+1,116	New	+$106K	﹤0.01%	3834

Other funds holding CALA

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DMPV

Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Parametric Portfolio Associates's CALA Position: Q1 2021 in Review

Parametric Portfolio Associates sold out of Calithera Biosciences, Inc (CALA) in Q1 2021, closing a stake of 708 shares — an estimated $70K sold.

Parametric Portfolio Associates first reported a position in CALA in Q3 2018 and held it in 9 quarters. The position peaked at $1.5M in Q2 2020. 100 funds tracked by Wall St. Rank hold CALA as of Q1 2021.

Parametric Portfolio Associates reported no remaining Calithera Biosciences, Inc position as of Q1 2021 after selling out during the quarter.
Parametric Portfolio Associates sold 708 Calithera Biosciences, Inc shares in Q1 2021, an estimated $70K.
Parametric Portfolio Associates first reported a position in Calithera Biosciences, Inc in Q3 2018 and held it in 9 quarters.
Parametric Portfolio Associates's Calithera Biosciences, Inc position peaked at $1.5M in Q2 2020.
100 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q1 2021.

Based on Parametric Portfolio Associates's 13F filing for Q1 2021, filed 17 May 2021.